The Horseracing Integrity and Safety Authority (HISA) seeks public comment on proposed modifications to the Rule Series 5000 (Equine Testing and Investigation Standards) and 7000 (Arbitration Procedures) of its Anti-Doping and Medication Control (ADMC) Program by Monday, Feb. 23, the regulator said via a press release on Thursday.
The proposed modifications build on HISA's ongoing review of the ADMC Program. In November, HISA distributed for public comment proposed modifications to other Rule Series comprising the ADMC Program (1000, 3000 and 4000). Comments received in response to that request are under review by the ADMC Committee.
The proposed updates to Rule Series 5000 and 7000 of the ADMC Program include:
- Clarification regarding the sample collection process;
- Introduction of voluntary, non-binding mediation in proceedings before the Arbitral Body;
- Expanded access for Owners to intervene in cases before the Internal Adjudication Panel.
A memorandum summarizing the proposed modifications is available here. A full draft of the proposed revisions in PDF redline format is available here. The redline reflects proposed updates compared to the version currently in effect and approved by the Federal Trade Commission (FTC).
Comments should be sent to HISA Assistant General Counsel Sam Reinhardt at Samuel.Reinhardt@hisaus.org with the subject line “Proposed Rule Modifications–Rule Series 5000 and 7000.”
Alternatively, comments may be mailed to HISA at 201 East Main Street, Suite 340, Lexington, KY 40507.
Following the expiration of the public comment period, the ADMC Committee, in consultation with the Horseracing Integrity & Welfare Unit, will review and consider all relevant feedback before recommending proposed modifications to the HISA Board. If approved by the HISA Board, the proposed modifications would then be submitted to the FTC.
Not a subscriber? Click here to sign up for the daily PDF or alerts.
